The Accumulation and Effects of Liposomal Doxorubicin in
Tissues Treated by Radiofrequency Ablation and Irreversible
Electroporation in Liver: In Vivo Experimental Study on Porcine
Models

J 2019

The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models

ANDRAŠINA, Tomáš, Josef JAROŠ, Tomáš JŮZA, Tomáš ROHAN, Dalibor ČERVINKA et. al.

Základní údaje

Originální název

The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models

Autoři

ANDRAŠINA, Tomáš (703 Slovensko, domácí), Josef JAROŠ (203 Česká republika, domácí), Tomáš JŮZA (203 Česká republika, garant, domácí), Tomáš ROHAN (203 Česká republika, domácí), Dalibor ČERVINKA (203 Česká republika), Michal CRHA (203 Česká republika), Vlastimil VÁLEK (203 Česká republika, domácí) a Nahum S. GOLDBERG (376 Izrael)

Vydání

Cardiovascular and Interventional Radiology, NEW YORK, SPRINGER, 2019, 0174-1551

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30224 Radiology, nuclear medicine and medical imaging

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.034

Kód RIV

RIV/00216224:14110/19:00108469

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s00270-019-02175-z

UT WoS

000462586800014

Klíčová slova anglicky

Liposomal doxorubicin; Radiofrequency ablation; Irreversible electroporation

Štítky

14110216, 14110517, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 31. 1. 2020 16:22, Mgr. Tereza Miškechová

Anotace

V originále

PurposeTo compare the accumulation and effect of liposomal doxorubicin in liver tissue treated by radiofrequency ablation (RFA) and irreversible electroporation (IRE) in in vivo porcine models.Materials and MethodsSixteen RFA and 16 IRE procedures were performed in healthy liver of two groups of three pigs. Multi-tined RFA parameters included: 100W, target temperature 105 degrees C for 7min. 100 IRE pulses were delivered using two monopolar electrodes at 2250V, 1Hz, for 100 mu sec. For each group, two pigs received 50mg liposomal doxorubicin (0.5mg/kg) as a drip infusion during ablation procedure, with one pig serving as control. Samples were harvested from the central and peripheral zones of the ablation at 24 and 72h. Immunohistochemical analysis to evaluate the degree of cellular stress, DNA damage, and degree of apoptosis was performed. These and the ablation sizes were compared. Doxorubicin concentrations were also analyzed using fluorescence photometry of homogenized tissue.ResultsRFA treatment zones created with concomitant administration of doxorubicin at 24h were significantly larger than controls (2.50.3cm vs. 2.2 +/- 0.2cm; p=0.04). By contrast, IRE treatment zones were negatively influenced by chemotherapy (2.2 +/- 0.4cm vs. 2.6 +/- 0.4cm; p=0.05). At 24h, doxorubicin concentrations in peripheral and central zones of RFA were significantly increased in comparison with untreated parenchyma (0.431 +/- 0.078 mu g/g and 0.314 +/- 0.055 mu g/g vs. 0.18 +/- 0.012 mu g/g; p<0.05). Doxorubicin concentrations in IRE zones were not significantly different from untreated liver (0.191 +/- 0.049 mu g/g and 0.210 +/- 0.049 mu g/g vs. 0.18 +/- 0.012 mu g/g).Conclusionsp id=Par4Whereas there is an increased accumulation of periprocedural doxorubicin and an associated increase in ablation zone following RFA, a contrary effect is noted with IRE. These discrepant findings suggest that different mechanisms and synergies will need to be considered in order to select optimal adjuvants for different classes of ablation devices.

Návaznosti

MUNI/A/1565/2018, interní kód MU

Název: Zdroje pro tkáňové inženýrství 9 (Akronym: TissueEng 9)

Investor: Masarykova univerzita, Zdroje pro tkáňové inženýrství 9, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

NV15-32484A, projekt VaV

Název: Využití nových biotechnologií v prevenci a léčbě stenóz žlučových cest

ROZV/24/LF/2018, interní kód MU

Název: LF - Příspěvek na IP 2108

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, LF - Příspěvek na IP 2108, Interní rozvojové projekty

Citovat

ANDRAŠINA, Tomáš, Josef JAROŠ, Tomáš JŮZA, Tomáš ROHAN, Dalibor ČERVINKA, Michal CRHA, Vlastimil VÁLEK a Nahum S. GOLDBERG. The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models. Cardiovascular and Interventional Radiology. NEW YORK: SPRINGER, 2019, roč. 42, č. 5, s. 751-762. ISSN 0174-1551. Dostupné z: https://dx.doi.org/10.1007/s00270-019-02175-z.

@article{1531617,
   author = {Andrašina, Tomáš and Jaroš, Josef and Jůza, Tomáš and Rohan, Tomáš and Červinka, Dalibor and Crha, Michal and Válek, Vlastimil and Goldberg, Nahum S.},
   article_location = {NEW YORK},
   article_number = {5},
   doi = {http://dx.doi.org/10.1007/s00270-019-02175-z},
   keywords = {Liposomal doxorubicin; Radiofrequency ablation; Irreversible electroporation},
   language = {eng},
   issn = {0174-1551},
   journal = {Cardiovascular and Interventional Radiology},
   title = {The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models},
   url = {http://dx.doi.org/10.1007/s00270-019-02175-z},
   volume = {42},
   year = {2019}
}

TY  - JOUR
ID  - 1531617
AU  - Andrašina, Tomáš - Jaroš, Josef - Jůza, Tomáš - Rohan, Tomáš - Červinka, Dalibor - Crha, Michal - Válek, Vlastimil - Goldberg, Nahum S.
PY  - 2019
TI  - The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models
JF  - Cardiovascular and Interventional Radiology
VL  - 42
IS  - 5
SP  - 751-762
EP  - 751-762
PB  - SPRINGER
SN  - 01741551
KW  - Liposomal doxorubicin
KW  - Radiofrequency ablation
KW  - Irreversible electroporation
UR  - http://dx.doi.org/10.1007/s00270-019-02175-z
L2  - http://dx.doi.org/10.1007/s00270-019-02175-z
N2  - PurposeTo compare the accumulation and effect of liposomal doxorubicin in liver tissue treated by radiofrequency ablation (RFA) and irreversible electroporation (IRE) in in vivo porcine models.Materials and MethodsSixteen RFA and 16 IRE procedures were performed in healthy liver of two groups of three pigs. Multi-tined RFA parameters included: 100W, target temperature 105 degrees C for 7min. 100 IRE pulses were delivered using two monopolar electrodes at 2250V, 1Hz, for 100 mu sec. For each group, two pigs received 50mg liposomal doxorubicin (0.5mg/kg) as a drip infusion during ablation procedure, with one pig serving as control. Samples were harvested from the central and peripheral zones of the ablation at 24 and 72h. Immunohistochemical analysis to evaluate the degree of cellular stress, DNA damage, and degree of apoptosis was performed. These and the ablation sizes were compared. Doxorubicin concentrations were also analyzed using fluorescence photometry of homogenized tissue.ResultsRFA treatment zones created with concomitant administration of doxorubicin at 24h were significantly larger than controls (2.50.3cm vs. 2.2 +/- 0.2cm; p=0.04). By contrast, IRE treatment zones were negatively influenced by chemotherapy (2.2 +/- 0.4cm vs. 2.6 +/- 0.4cm; p=0.05). At 24h, doxorubicin concentrations in peripheral and central zones of RFA were significantly increased in comparison with untreated parenchyma (0.431 +/- 0.078 mu g/g and 0.314 +/- 0.055 mu g/g vs. 0.18 +/- 0.012 mu g/g; p<0.05). Doxorubicin concentrations in IRE zones were not significantly different from untreated liver (0.191 +/- 0.049 mu g/g and 0.210 +/- 0.049 mu g/g vs. 0.18 +/- 0.012 mu g/g).Conclusionsp id=Par4Whereas there is an increased accumulation of periprocedural doxorubicin and an associated increase in ablation zone following RFA, a contrary effect is noted with IRE. These discrepant findings suggest that different mechanisms and synergies will need to be considered in order to select optimal adjuvants for different classes of ablation devices.
ER  -

ANDRAŠINA, Tomáš, Josef JAROŠ, Tomáš JŮZA, Tomáš ROHAN, Dalibor ČERVINKA, Michal CRHA, Vlastimil VÁLEK a Nahum S. GOLDBERG. The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models. \textit{Cardiovascular and Interventional Radiology}. NEW YORK: SPRINGER, 2019, roč.~42, č.~5, s.~751-762. ISSN~0174-1551. Dostupné z: https://dx.doi.org/10.1007/s00270-019-02175-z.

Podrobný výpis o publikaci